Comorbidity of the nonmotor symptoms of Parkinson's disease

被引:324
|
作者
Shulman, LM
Taback, RL
Bean, J
Weiner, WJ
机构
[1] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA
[2] Intecardia, Chapel Hill, NC USA
[3] Univ Cincinnati, Childrens Hosp, Med Ctr, Biostat Unit, Cincinnati, OH USA
关键词
depression; anxiety; fatigue; sleep disturbance;
D O I
10.1002/mds.1099
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Many patients with Parkinson's disease (PD) have clinically significant anxiety, depression, fatigue, sleep disturbance:, or sensory symptoms. The comorbidity of these nonmotor symptoms and their relationship to PD severity has not been extensively evaluated, Ninety- nine nondemented PD patients were evaluated with the following battery of tests: Beck Anxiety Inventory (BAI), Beck Depression Inventory (BDI), Fatigue Severity Scale (FSS), Pittsburgh Sleep Quality Index (PSQI), a sensory symptom questionnaire, Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn & Yahr (H/Y) Stage, and the Schwab & England ADL scale (S/E). The comorbidity of the nonmotor symptoms and their relationship to PD severity was analyzed. Thirty-six percent of the study population had depression (BDI greater than or equal to 10), 33% had anxiety (BAI greater than or equal to 10), 40% had fatigue (FSS > 4), 47% had sleep disturbance (PSQI > 5), and 63% reported sensory symptoms. Only 12% of the sample had no nonmotor symptoms. Fifty-nine percent of the patients had two or more nonmotor symptoms, and nearly 25% had four or more. Increased comorbidity was associated with greater PD severity (P < 001). This study reveals that the nonmotor symptoms of PD frequently occur together in the same patients. Increased comorbidity of the five nonmotor symptoms was associated with greater PD severity. These results suggest that recognition of these diverse nonmotor symptoms may be enhanced by looking for others when one nonmotor symptom has been identified. (C) 2001 Movement Disorder Society.
引用
收藏
页码:507 / 510
页数:4
相关论文
共 50 条
  • [41] Effects of Ropinirole on Nonmotor Symptoms of Parkinson Disease: A Prospective Multicenter Study
    Rektorova, Irena
    Balaz, Marek
    Svatova, Jindra
    Zarubova, Katerina
    Honig, Igor
    Dostal, Vaclav
    Sedlackova, Silvie
    Nestrasil, Igor
    Mastik, Jiri
    Bares, Martin
    Veliskova, Jana
    Dusek, Ladislav
    CLINICAL NEUROPHARMACOLOGY, 2008, 31 (05) : 261 - 266
  • [42] Nonmotor Symptoms Affect Sleep Quality in Early-Stage Parkinson's Disease Patients With or Without Cognitive Dysfunction
    Zhu, Jun
    Zhong, Min
    Yan, Jun
    Jiang, Xu
    Wu, Zhuang
    Pan, Yang
    Shen, Bo
    Zhang, Lili
    Dong, Jingde
    Zhang, Li
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [43] Mindfulness for Motor and Nonmotor Dysfunctions in Parkinson's Disease
    Dissanayaka, Nadeeka N. W.
    Jion, Farah Idu
    Pachana, Nancy A.
    O'Sullivan, John D.
    Marsh, Rodney
    Byrne, Gerard J.
    Harnett, Paul
    PARKINSONS DISEASE, 2016, 2016
  • [44] Treatment strategies for nonmotor manifestations of Parkinson's disease
    Reichmann, Heinz
    Ziemssen, Tjalf
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (05) : 773 - 784
  • [45] Decreased Striatal Vesicular Monoamine Transporter Type 2 Correlates With the Nonmotor Symptoms in Parkinson Disease
    Shi, Xinchong
    Zhang, Yan
    Xu, Shaohua
    Kung, Hank F.
    Qiao, Hongwen
    Jiang, LuLu
    Zhu, Lin
    Guo, Qiyi
    Yi, Chang
    Luo, Ganhua
    Wu, Lei
    Pei, Zhong
    Wang, Jian
    Zhang, Xiangsong
    Chen, Ling
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 707 - 713
  • [46] The diabetic parkinsonian - the association of diabetes mellitus comorbidity and symptoms of Parkinson's disease
    Chmiela, Tomasz
    Wegrzynek-Gallina, Julia
    Wilczek, Dawid
    Waksmundski, Damian
    Kasprzyk, Amadeusz
    Ciesla-Fulawka, Aleksandra
    Gorzkowska, Agnieszka
    AKTUALNOSCI NEUROLOGICZNE, 2024, 24 (01): : 1 - 7
  • [47] Combined Rasagiline and Antidepressant Use in Parkinson Disease in the ADAGIO Study Effects on Nonmotor Symptoms and Tolerability
    Smith, Kara M.
    Eyal, Eli
    Weintraub, Daniel
    JAMA NEUROLOGY, 2015, 72 (01) : 88 - 95
  • [48] Nonmotor versus motor symptoms: How much do they matter to health status in Parkinson's disease?
    Hinnell, Claire
    Hurt, Catherine S.
    Landau, Sabine
    Brown, Richard G.
    Samuel, Michael
    MOVEMENT DISORDERS, 2012, 27 (02) : 236 - 241
  • [49] New Targets for Treating the Underlying Pathophysiology and Nonmotor Aspects of Parkinson's Disease
    Butler, Jonathan T.
    Tolleson, Christopher
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (07) : 1273 - 1279
  • [50] Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations
    Auffret, Manon
    Le Jeune, Florence
    Maurus, Anne
    Drapier, Sophie
    Houvenaghel, Jean-Francois
    Robert, Gabriel Hadrien
    Sauleau, Paul
    Verin, Marc
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 372 : 279 - 287